ibandronate sodium
Generic: ibandronate sodium
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
ibandronate sodium
Generic Name
ibandronate sodium
Labeler
aurobindo pharma limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
ibandronate sodium 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
65862-237
Product ID
65862-237_6d9a3f36-83b1-4d1b-ab7d-582b3551839b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA204502
Listing Expiration
2027-12-31
Marketing Start
2016-03-11
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862237
Hyphenated Format
65862-237
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ibandronate sodium (source: ndc)
Generic Name
ibandronate sodium (source: ndc)
Application Number
ANDA204502 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM COATED in 1 BLISTER PACK
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6d9a3f36-83b1-4d1b-ab7d-582b3551839b", "openfda": {"unii": ["J12U072QL0"], "rxcui": ["904932"], "spl_set_id": ["86c0b4ae-5e38-4efe-88af-50ac560e294f"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "65862-237-03", "marketing_start_date": "20160311"}], "brand_name": "Ibandronate Sodium", "product_id": "65862-237_6d9a3f36-83b1-4d1b-ab7d-582b3551839b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "65862-237", "generic_name": "Ibandronate Sodium", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ibandronate Sodium", "active_ingredients": [{"name": "IBANDRONATE SODIUM", "strength": "150 mg/1"}], "application_number": "ANDA204502", "marketing_category": "ANDA", "marketing_start_date": "20160311", "listing_expiration_date": "20271231"}